Generex definitely needs to file a Q that shows evidence of revenue to bring confidence in their acquisition strategy. Does Hema sell anything? One order of malaria kits that sell for a few bucks? MediSource and Pantheon will be included in the next Q. That deal was very lucrative to Mr Bird. Their ebitda targets are super low. Joe says the strategy is to bring value in so that needs to actually show itself.